Association between serum potassium and outcomes in patients with reduced kidney function

Clinical Journal of the American Society of Nephrology

Volumn 11, Issue 1, 2016, Pages 90-100

  Luo, Jiacong ^a   Brunelli, Steven M ^a   Jensen, Donna E ^a   Yang, Alex ^b  

^a DAVITA CLINICAL RESEARCH   (United States)

^b ZS Pharma Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANALYSIS OF VARIANCE; ARTICLE; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; HOSPITALIZATION; HUMAN; HYPERKALEMIA; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; POTASSIUM BLOOD LEVEL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RETROSPECTIVE ASSESSMENT; SENSITIVITY ANALYSIS; AGED; BLOOD; CARDIOVASCULAR DISEASES; GLOMERULUS FILTRATION RATE; KIDNEY FAILURE, CHRONIC; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; VERY ELDERLY;

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; POTASSIUM;

AGED; AGED, 80 AND OVER; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOVASCULAR DISEASES; FEMALE; GLOMERULAR FILTRATION RATE; HOSPITALIZATION; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; POTASSIUM; RETROSPECTIVE STUDIES;

EID: 84954459844     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.01730215     Document Type: Article

References (19)

1. Hoskote SS, Joshi SR, Ghosh AK: Disorders of potassium homeostasis: Pathophysiology and management. J Assoc Physicians India 56: 685-693, 2008
2. Ishii K, Norota I, Obara Y: Endocytic regulation of voltagedependent potassium channels in the heart. J Pharmacol Sci 120: 264-269, 2012
3. Petkov GV: Role of potassium ion channels in detrusor smooth muscle function and dysfunction. Nat Rev Urol 9: 30-40, 2012
4. Poolos NP, Johnston D: Dendritic ion channelopathy in acquired epilepsy. Epilepsia 53[Suppl 9]: 32-40, 2012
5. An JN, Lee JP, Jeon HJ, Kim H, Oh YK, Kim YS, Lim CS: Severe hyperkalemia requiring hospitalization: predictors of mortality. Crit Care 16: R225, 2012
6. Einhorn LM, Zhan M, Hsu VD, Walker LD, Moen MF, Seliger SL, Weir MR, Fink JC: The frequency of hyperkalemia and its significance in chronic kidney disease. Arch Intern Med 169: 1156-1162, 2009
7. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3: 1-150, 2013
8. Weir MR, Rolfe M: Potassium homeostasis and renin-angiotensin aldosterone system inhibitors. Clin J Am Soc Nephrol 5: 531-548, 2010
9. Sarafidis PA, Blacklock R, Wood E, Rumjon A, Simmonds S, Fletcher-Rogers J, Ariyanayagam R, Al-Yassin A, Sharpe C, Vinen K: Prevalence and factors associated with hyperkalemia in predialysis patients followed in a low-clearance clinic. Clin J Am Soc Nephrol 7: 1234-1241, 2012
10. Korgaonkar S, Tilea A, Gillespie BW, Kiser M, Eisele G, Finkelstein F, Kotanko P, Pitt B, Saran R: Serum potassium and outcomes in CKD: Insights from the RRI-CKD cohort study. Clin J Am Soc Nephrol 5: 762-769, 2010
11. Bowling CB, Pitt B, Ahmed MI, Aban IB, Sanders PW, Mujib M, Campbell RC, Love TE, Aronow WS, Allman RM, Bakris GL, Ahmed A: Hypokalemia and outcomes in patients with chronic heart failure and chronic kidney disease: Findings from propensity-matched studies. Circ Heart Fail 3: 253-260, 2010
12. Wiebe N, Klarenbach SW, Allan GM, Manns BJ, Pelletier R, James MT, Bello A, Hemmelgarn BR, Tonelli M; Alberta Kidney Disease Network: Potentially preventable hospitalization as a complication of CKD: A cohort study. Am J Kidney Dis 64: 230-238, 2014
13. Elliott MJ, Ronksley PE, Clase CM, Ahmed SB, Hemmelgarn BR: Management of patients with acute hyperkalemia. CMAJ 182: 1631-1635, 2010
14. Wang HH, Hung CC, Hwang DY, Kuo MC, Chiu YW, Chang JM, Tsai JC, Hwang SJ, Seifter JL, Chen HC: Hypokalemia, its contributing factors and renal outcomes in patients with chronic kidney disease. PLoS One 8: e67140, 2013
15. Acker CG, Johnson JP, Palevsky PM, Greenberg A: Hyperkalemia in hospitalized patients: Causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines. Arch Intern Med 158: 917-924, 1998
16. Ahmed A, Husain A, Love TE, Gambassi G, Dell’Italia LJ, Francis GS, Gheorghiade M, Allman RM, Meleth S, Bourge RC: Heart failure, chronic diuretic use, and increase in mortality and hospitalization: An observational study using propensity score methods. Eur Heart J 27: 1431-1439, 2006
17. Watson M, Abbott KC, Yuan CM: Damned if you do, damned if you don’t: Potassium binding resins in hyperkalemia. Clin J Am Soc Nephrol 5: 1723-1726, 2010
18. Sterns RH, Rojas M, Bernstein P, Chennupati S: Ion-exchange resins for the treatment of hyperkalemia: Are they safe and effective? J Am Soc Nephrol 21: 733-735, 2010
19. Kovesdy CP, Regidor DL, Mehrotra R, Jing J, McAllister CJ, Greenland S, Kopple JD, Kalantar-Zadeh K: Serum and dialysate potassium concentrations and survival in hemodialysis patients. Clin J Am Soc Nephrol 2: 999-1007, 2007